The eLife journal is a first step in this unique funder-researcher collaboration to catalyse innovation in research communication. (NEW: journal site launched December 13, 2012)
Involving the Howard Hughes Medical Institute, the Max Planck Society, the Wellcome Trust, and over 200 of the world’s most talented biomedical scientists, we are convinced that eLife will rapidly gain community confidence as a venue for outstanding work.
eLife is a researcher-led digital publication for outstanding work, a platform to maximise the reach and influence of new findings and a showcase for new approaches for the presentation and assessment of research.
We aim to make eLife the leading choice for all researchers, in particular for early-career researchers. It’s important that early experiences of publishing are constructive and fair. We’ll deliver a top publishing venue to advance careers in science; we’ll make decisions quickly; deliver a fair, transparent, and supportive author experience; and create maximum potential exposure for published works.
At eLife, our goal is to accelerate scientific advancement by promoting modes of communication whereby new results are made available quickly, openly, and in a way that helps others to build upon them. We will make data more accessible, more useable. We’ll aim to create a broader audience for important discoveries, and we’ll work to trace the impact of individual contributions – on individual fields of study, on science, and on society as a whole.
At eLife, publication is just one step toward full realisation of the impact of effective research communication. Publication is just the beginning.
The eLife journal (ISSN 2050-084X) is published by eLife Sciences Publications, Ltd.
